Background: The BRAF V600E mutation is the most frequent genetic alteration in papillary
thyroid carcinoma (PTC). The role of BRAF V600E mutation as a poor prognostic factor has …

… almost 2.1% of newly diagnosed cancer cases (1). Papillary thyroid carcinoma (PTC) is
the most common histological type of differentiated thyroid carcinoma accounting for 75–85% …

BACKGROUND: The effects of the BRAF V600E mutation on prognostic factors and poor
clinical outcomes in papillary thyroid cancer (PTC) have not been fully quantified. The authors …

… papillary thyroid cancer. We identified studies reporting BRAF V600E mutation analysis after
FNA for evaluation of thyroid … confidence interval, 61%-76%) for papillary thyroid cancer. For …

… of the BRAF V600E mutation using thyroid cancer tissue from 424 patients who underwent
… cases (79%) and was higher in classic papillary thyroid carcinoma (PTC) (79.7%) than in …

… alteration in papillary thyroid carcinoma (PTC), and in anaplastic thyroid carcinoma as well,
… collagens and laminins) and promotes thyroid cancer migration and invasion. BRAF V600E …

… worldwide increase in the prevalence of papillary thyroid cancer (PTC) as well as a number
of changes in the clinicopathological characteristics of this disease. BRAF V600E , which is a …

… Our dataset included an unselected cohort of papillary thyroid carcinoma (PTC) patients
who underwent a total thyroidectomy (or unilateral then completion thyroidectomy) at a single …

… and primarily involves papillary thyroid cancer (PTC). The BRAFV600E mutation is the most
… variations in the frequency of the BRAFV600E mutation in PTC that were diagnosed at a …

BACKGROUND: The role of the B-isoform of the Raf kinase (BRAF) mutation BRAF V600E
as an independent prognostic factor in papillary thyroid cancer (PTC) remains controversial. …